Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Milestone Pharmaceuticals Inc.(MIST) | 658,553 | 755,000 | +96,447 | $1.32M | $1.53M | 7.89% | +$208.0K |
| Praxis Precision Medicines, Inc.(PRAX) | 5,700 | 4,450 | -1,250 | $302.1K | $1.31M | 6.79% | +$1.01M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 67,500 | 67,500 | 0 | $484.0K | $889.6K | 4.60% | +$405.7K |
| Fennec Pharmaceuticals Inc.(FENC) | 123,000 | 112,434 | -10,566 | $1.15M | $865.7K | 4.48% | -$285.5K |
| Jasper Therapeutics, Inc.(JSPR) | 398,558 | 465,000 | +66,442 | $948.6K | $851.0K | 4.40% | -$97.6K |
| Benitec Biopharma Inc.(BNTC) | 62,000 | 62,000 | 0 | $869.9K | $835.1K | 4.32% | -$34.7K |
| Royalty Pharma plcCL A(RPRX) | 21,400 | 21,400 | 0 | $755.0K | $826.9K | 4.28% | +$71.9K |
| Geron Corporation(GERN) | 500,000 | 578,000 | +78,000 | $685.0K | $763.0K | 3.95% | +$78.0K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 55,000 | 36,000 | -19,000 | $846.2K | $756.4K | 3.91% | -$89.8K |
| Ardelyx Inc | 162,750 | 128,650 | -34,100 | $896.8K | $750.0K | 3.88% | -$146.7K |
| Cue Biopharma, Inc.(CUE) | 0 | 2,202,854 | +2,202,854 | $0 | $672.8K | 3.48% | +$672.8K |
| Disc Medicine, Inc.(IRON) | 10,600 | 8,100 | -2,500 | $700.4K | $643.2K | 3.33% | -$57.2K |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 28,500 | +28,500 | $0 | $613.3K | 3.17% | +$613.3K |
| Biohaven Ltd.(BHVN) | 22,700 | 51,700 | +29,000 | $340.7K | $583.7K | 3.02% | +$243.0K |
| Humacyte, Inc.(HUMA) | 83,500 | 500,000 | +416,500 | $145.3K | $480.3K | 2.49% | +$335.0K |
| Kura Oncology, Inc.(KURA) | 46,000 | 46,000 | 0 | $407.1K | $477.9K | 2.47% | +$70.8K |
| Seres Therapeutics, Inc.(MCRB) | 27,138 | 31,570 | +4,432 | $522.1K | $469.8K | 2.43% | -$52.4K |
| COMPASS Pathways plcADS(CMPS) | 58,000 | 58,000 | 0 | $332.3K | $400.2K | 2.07% | +$67.9K |
| Day One Biopharmaceuticals I COM | 42,000 | 42,000 | 0 | $296.1K | $391.4K | 2.03% | +$95.3K |
| REGENXBIO Inc.(RGNX) | 57,750 | 26,600 | -31,150 | $557.3K | $383.0K | 1.98% | -$174.2K |
| BridgeBio Pharma, Inc.(BBIO) | 13,300 | 5,000 | -8,300 | $690.8K | $382.4K | 1.98% | -$308.4K |
| Mineralys Therapeutics, Inc.(MLYS) | 39,000 | 10,500 | -28,500 | $1.48M | $381.0K | 1.97% | -$1.10M |
| Ventyx Biosciences Inc | 0 | 41,500 | +41,500 | $0 | $374.7K | 1.94% | +$374.7K |
| Lantheus Holdings, Inc.(LNTH) | 0 | 5,500 | +5,500 | $0 | $366.0K | 1.89% | +$366.0K |
| Dyne Therapeutics, Inc.(DYN) | 0 | 18,000 | +18,000 | $0 | $352.1K | 1.82% | +$352.1K |
| uniQure N.V.SHS(QURE) | 0 | 14,700 | +14,700 | $0 | $351.8K | 1.82% | +$351.8K |
| Pacira BioSciences, Inc.(PCRX) | 0 | 13,500 | +13,500 | $0 | $349.4K | 1.81% | +$349.4K |
| Viatris Inc.(VTRS) | 0 | 27,700 | +27,700 | $0 | $344.9K | 1.78% | +$344.9K |
| Azenta, Inc.(AZTA) | 0 | 9,700 | +9,700 | $0 | $322.6K | 1.67% | +$322.6K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 86,000 | 86,000 | 0 | $280.4K | $301.9K | 1.56% | +$21.5K |
| Janux Therapeutics, Inc.(JANX) | 0 | 19,000 | +19,000 | $0 | $262.2K | 1.36% | +$262.2K |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 9,100 | +9,100 | $0 | $225.8K | 1.17% | +$225.8K |
| Innoviva, Inc.(INVA) | 0 | 8,200 | +8,200 | $0 | $163.9K | 0.85% | +$163.9K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 35,300 | 5,250 | -30,050 | $665.4K | $152.5K | 0.79% | -$512.9K |
| Innate Pharma S.A.ADS(IPHA) | 0 | 81,151 | +81,151 | $0 | $142.0K | 0.73% | +$142.0K |
| Minerva Neurosciences, Inc.(NERV) | 0 | 35,000 | +35,000 | $0 | $140.7K | 0.73% | +$140.7K |
| GH Research PLC(GHRS) | 0 | 10,200 | +10,200 | $0 | $129.5K | 0.67% | +$129.5K |
| Spruce Biosciences Inc | 1,000 | 1,000 | 0 | $8.9K | $87.1K | 0.45% | +$78.2K |
| Mersana Therapeutics Inc | 25,760 | 100 | -25,660 | $199.9K | $2.9K | 0.01% | -$197.0K |
| Avadel Pharmaceuticals Plc | 59,700 | 0 | -59,700 | $911.6K | $0 | — | -$911.6K |
| Insmed Incorporated(INSM) | 6,250 | 0 | -6,250 | $900.1K | $0 | — | -$900.1K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 23,400 | 0 | -23,400 | $908.6K | $0 | — | -$908.6K |